Answers are grounded in this paper and cite their sources.
// Hong-Xia Zhang 1, 2 , Shan-Shan Jiang 1, 2 , Xiao-Fei Zhang 1, 2 , Zi-Qi Zhou 1, 2 , Qiu-Zhong Pan 1, 2 , Chang-Long Chen 1, 2 , Jing-Jing Zhao 1, 2 , Yan Tang 1, 2 , Jian-Chuan Xia 1, 2 , De-Sheng Weng 1, 2 1 Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China 2 Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, China Correspondence to: De-Sheng Weng, e-mail: wengdsh@sysucc.org.cn Jian-Chuan Xia, e-mail: xiajch@mail.sysu.edu.cn Keywords: CK2α, hepatocellular carcinoma, prognosis, oncogene, apoptosis Received: April 14, 2015 Accepted: September 15, 2015 Published: September 25, 2015 ABSTRACT Protein kinase CK2 alpha (CK2α), one isoform of the catalytic subunit of serine/threonine kinase CK2, has been indicated to participate in tumorigenesis of various malignancies. We conducted this study to investigate the biological significances of CK2α expression in hepatocellular carcinoma (HCC) development. Real-time quantitative polymerase and western blotting analyses revealed that CK2α expression was significantly increased at mRNA and protein levels in HCC tissues. Immunohistochemical analyses indicated that amplified expression of CK2α was highly correlated with poor prognosis. And functional analyses (cell proliferation and colony formation assays, cell migration and invasion assays, cell cycle and apoptosis assays) found that CK2α promoted cell proliferation, colony formation, migration and invasion, as well as inhibited apoptosis in hepatoma cell lines in vitro . CK2α-silenced resulted in significant apoptosis in cells that was demonstrated been associated with downregulation of expression of Bcl-2, p -AKT (ser473) and upregulation of expression of total P53, p -P53, Bax, caspase3 and cleaved-caspase3 in HCC cells. In addition, experiments with a mouse model revealed that the stimulative effect of CK2α on tumorigenesis in nude mice. Our results suggest that CK2α might play an oncogenic role in HCC, and therefore it could serve as a biomarker for prognostic and therapeutic applications in HCC.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: